Nan Zheng

U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer

Harpreet Singh, Amanda J. Walker, Laleh Amiri‐Kordestani et al. · Clinical Cancer Research · 2018 · 97 citations · Full text

Medicine, Oncology, Pharmacology +17

FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies

Linda Jo Bone Jeng, Solomon Chefo, Yan Wang et al. · Genetics in Medicine · 2022 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +2

FDA Approval Summary: Mobocertinib for Metastatic Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations

Elizabeth S. Duke, Liza Stapleford, Nicole Drezner et al. · Clinical Cancer Research · 2022 · 40 citations · Full text

Medicine, Oncology, Pharmacology +15

FDA Approval Summary: Teclistamab–A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma

Andrea Baines, Bindu Kanapuru, Jay Zhao et al. · Clinical Cancer Research · 2024 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16